Skip to main content
Log in

Sufoxazine

Lucelan®, Metatone®, Teniloxazine, Y 8894

  • Section 2: Dementia Syndrome in Japan
  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Orlando R, Benvenuti C, Mazzo M, et al. The pharmacokinetics of teniloxazine in healthy subjects and patients with hepatic cirrhosis. Br J Clin Pharmacol 1995 Apr; 39: 445–8

    Article  PubMed  CAS  Google Scholar 

  2. Aguglia E, Caraceni T, Genitrini S, et al. Comparison of teniloxazine and piracetam in Alzheimer-type or vascular dementia. Curr Ther Res 1995 Mar; 56: 250–7

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sufoxazine. Drugs R&D 2, 144–145 (1999). https://doi.org/10.2165/00126839-199902020-00017

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199902020-00017

Keywords

Navigation